The human crisis in cancer: a Lancet Oncology Commission +++ +... +...

The human crisis in cancer: a Lancet Oncology Commission https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00530-3/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonchumancrisis25&_hsenc=p2ANqtz-94fetq1vGdvWZDO3pp-EjOYilJuyzikIri8HItCql1C-Uu0zm1_UtKSeKrWnN8VjSy5DRtVwliZtt9JyDl_-697HmKiQ&_hsmi=393481175&utm_content=393481751&utm_source=hs_emai Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00605-9/fulltext?dgcid=hubspot_update_feature_updatealerts_lanonc&utm_campaign=update-lanonc&utm_medium=email&_hsenc=p2ANqtz-9vJMUgjXJTCDokG3vo5eBLhJouw8eqq055bEDVWIjXdNWSsOic-Nd1OQV-wQKGkcmWZgKMSt7-LSFrxvi0ie_6GEyqYQ&_hsmi=393481175&utm_content=393481751&utm_source=hs_email A deliverable national cancer control plan for the UK: lessons from abroad and the need for discipline at home https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00650-3/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-_90KQwEJ63A_9uzlvppqK8wM1p1b8M4P5nJJo8txpR96YMW2dyv9pzEh_hKBa536DwzvFgSxm5g0oQVDNhyTddwoAvnA&_hsmi=393481175&utm_content=393481751&utm_source=hs_email ESMO | European Society for Medical Oncology https://www.thelancet.com/events/conferences/european-society-medical-oncology?dgcid=hubspot_update_feature_esmo25_lancet&utm_campaign=update-lanonc&utm_medium=email&_hsenc=p2ANqtz--mXvo33u7v4hDFZSPBx1SkvZdWR7fPN_P3mfoLBRZsc_ousgbKH10q2CPMwRBdtOk-KjtiiioBxhjS1wuuj6xNjjoqwg&_hsmi=393481175&utm_content=393481751&utm_source=hs_email Dec 2025 Volume 26Number 12p1511-1684, e620-e706 https://www.thelancet.com/journals/lanonc/issue/vol26no12/PIIS1470-2045(25)X0012-7